Hyafilia ME:DAM is a range of innovative fillers created by CHA Meditech Co., Ltd. from South Korea. They have developed a unique structure of hyaluronic acid that combines the best qualities of both monophasic and biphasic fillers. The formulation is made up of 85% stabilized substance and 15% native substance. The Hyafilia ME:DAM range includes L. P. D.
Hyafilia ME:DAM Light Plus is a filler that is less dense compared to other fillers in the series. It is injected into the surface layers of the dermis, and is made up of 85% stabilized hyaluronic acid and 15% free hyaluronic acid. The product has the qualities of both monophasic and biphasic fillers, with optimal plasticity that avoids excessive viscosity and the formation of clots under the skin.
ME:DAM Light Plus
HA 20mg/mL, Lido 0.3mg
ME:DAM is a dermal filler that combines qualities of both mono-and biphasic fillers and contains hyaluronic acid (HA) at a concentration of 20mg/ml, with the addition of Lido at a concentration of 0.3%
1.0mL x 1syringe
ME:DAM Prime Plus
HA 20mg/mL, Lido 0.3mg
ME:DAM is a dermal filler that combines qualities of both mono-and biphasic fillers and contains hyaluronic acid (HA) at a concentration of 20mg/ml, with the addition of Lido at a concentration of 0.3%
1.0mL x 1syringe
ME:DAM Deep Plus
HA 20mg/mL, Lido 0.3mg
ME:DAM is a dermal filler that combines qualities of both mono-and biphasic fillers and contains hyaluronic acid (HA) at a concentration of 20mg/ml, with the addition of Lido at a concentration of 0.3%
1.0mL x 1syringe
--------------------------------------------------------------------------------------------------------------------------------------------------
--------------------------------------------------------------------------------------------------------------------------------------------------

DERMANIC
specializes in the distribution of fillers, botulinum toxins, skin boosters, and medical cosmetic products.With advanced technology and strict quality standards,we deliver safe and effective solutions to clients worldwide.